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Abstract
Background: The epidemiology of non-Typhi Salmonella (NTS) bacteremia in Africa will likely evolve as potential co-factors,
such as HIV, malaria, and urbanization, also change.
Methods: As part of population-based surveillance among 55,000 persons in malaria-endemic, rural and malaria-
nonendemic, urban Kenya from 2006–2009, blood cultures were obtained from patients presenting to referral clinics with
fever $38.0uC or severe acute respiratory infection. Incidence rates were adjusted based on persons with compatible
illnesses, but whose blood was not cultured.
Results: NTS accounted for 60/155 (39%) of blood culture isolates in the rural and 7/230 (3%) in the urban sites. The
adjusted incidence in the rural site was 568/100,000 person-years, and the urban site was 51/100,000 person-years. In both
sites, the incidence was highest in children ,5 years old. The NTS-to-typhoid bacteremia ratio in the rural site was 4.6 and in
the urban site was 0.05. S. Typhimurium represented .85% of blood NTS isolates in both sites, but only 21% (urban) and
64% (rural) of stool NTS isolates. Overall, 76% of S. Typhimurium blood isolates were multi-drug resistant, most of which had
an identical profile in Pulse Field Gel Electrophoresis. In the rural site, the incidence of NTS bacteremia increased during the
study period, concomitant with rising malaria prevalence (monthly correlation of malaria positive blood smears and NTS
bacteremia cases, Spearman’s correlation, p=0.018 for children, p=0.16 adults). In the rural site, 80% of adults with NTS
bacteremia were HIV-infected. Six of 7 deaths within 90 days of NTS bacteremia had HIV/AIDS as the primary cause of death
assigned on verbal autopsy.
Conclusions: NTS caused the majority of bacteremias in rural Kenya, but typhoid predominated in urban Kenya, which most
likely reflects differences in malaria endemicity. Control measures for malaria, as well as HIV, will likely decrease the burden
of NTS bacteremia in Africa.
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Introduction
Non-Typhi Salmonella (NTS) is a common cause of bacteremia
among children and adults in Africa [1–12]. NTS bacteremia in
Africa is highly associated with other diseases, particularly HIV
and malnutrition, and possibly malaria [2,9,10,12]. As the
epidemiology of these associated diseases evolves in Africa, the
epidemiology and burden of NTS bacteremia may also change.
Moreover, recent reports of a multi-drug resistant NTS clone,
causing invasive disease in Africa suggests that the epidemiology of
NTS bacteremia might also be in flux due to other selective
pressures [13,14]. Lastly, as more Africans migrate to urban areas,
living in crowded, squalid conditions, these new environments
might also lead to a different epidemiology of NTS bacteremia.
Updated epidemiologic data on NTS bacteremia can serve to
guide future policy decisions on treatment and prevention.
We evaluated three years of population-based surveillance on
NTS bacteremia from an urban informal settlement in Nairobi
and a rural area of western Kenya. Our surveillance highlights
stark differences in invasive Salmonella epidemiology in urban and
rural Africa and the close associations between NTS bacteremia
and HIV and malaria.
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Study sites
The Centers for Disease Control and Prevention’s (CDC)
International Emerging Infections Program (IEIP) and the Kenya
Medical Research Institute (KEMRI) have conducted population-
based morbidity surveillance since late 2005 in Asembo, in rural
western Kenya and in Kibera, an informal settlement in Nairobi.
The surveillance sites and design have been described previously
[15,16]. In brief, the population from July, 2006 included
approximately 25,000 and 30,000 persons in the rural and urban
areas, respectively [15,16]. All participants must have resided
permanently in the surveillance area for four calendar months
[17]. In Asembo, malaria transmission is intense and occurs year-
round [17]. In Kibera, the population lives in crowded conditions,
with dirt paths between the dwellings and open sewers. Malaria is
not endemic, but does occur particularly among those travelling to
visit family in rural areas. Both sites have high adult prevalence of
HIV at 15–17% (KEMRI/CDC unpublished data).
Surveillance methods
Study participants receive free medical care for most acute
conditions at a single referral health facility centrally-located in each
site (Lwak Hospital in Asembo, Tabitha Clinic in Kibera). Patients are
examined and diagnosed by clinical officers (similar to physician’s
assistants). Scannable paper questionnaires (TeleFormH,C a r d i f f
TM,
California) or computerized databases (GFL Partners, Kenya) are
completed on all sick visits, documenting symptoms, health-seeking,
physical exam, diagnosis, treatment and outcome. Blood cultures are
done on persons meeting one of three case definitions.
1. Severe acute respiratory illness (SARI), defined in persons $5
years old as cough or difficulty breathing and either
temperature $38.0uC or oxygen saturation ,90%, and in
children ,5 years old as those with clinical pneumonia as
defined by WHO’s Integrated Management of Childhood
Illness [18].
2. Acute febrile illness, defined as a temperature $38.0uC,
without SARI or other obvious source (e.g. bloody diarrhea),
irrespective of malaria blood smear result (only the first two
child and first two adult patients who meet this criteria per day
are enrolled).
3. All patients, regardless of age, admitted for conditions
unrelated to injury or obstetrics, at Lwak Hospital. (Tabitha
Clinic does not have inpatient capacity.)
In addition, blood smears for malaria are done and read by
KEMRI/CDC trained microscopists in the clinics, who undergo
regular quality assurance evaluations. Stools are also collected,
either in specimen cups or by rectal swabs, on patients with
diarrheal illness ($3 looser-than-normal stools in a 24-hour
period), regardless of the presence of bloody diarrhea. Swabs of
whole stool and rectal swabs were placed immediately in Cary-
Blair transport medium and cooled to 4–8uC in insulated
containers and shipped on the same day for immediate processing
in KEMRI/CDC laboratories [19].
Community interviewers visit enrolled households every two
weeks to inquire about illnesses. Symptoms are recorded and an
abbreviated physical exam is done by trained field workers.
Participants are asked if and where they sought health care. Using
household visit data, we defined SARI as an episode with cough or
difficulty breathing and documented fever and defined acute
febrile illness as someone with reported fever without cough,
difficulty breathing, or bloody diarrhea.
Table 1. Results of blood culture among patients with fever and/or severe acute respiratory illness, rural and urban Kenya, 2006–
2009.
Age in years 0–4 5–9 10–17 18–49 .50 Total
Rural Kenya
Number patients (N) 12,698 6,292 7,249 9,840 3,940 40,019
Number of blood cultures, n (% patients) 1,647(13.0) 708(11.3) 372 (5.1) 656 (6.7) 195(4.9) 3,578 (8.9)
Positive blood cultures, n (%cultures) 43(2.6) 13(1.8) 11 (3.0) 67(9.3) 18(9.2) 155 (4.3)
NTS recovered, n (% positive cultures) 28 (65.1) 6 (46.2) 1 (9.1) 19(28.4) 6(33.3) 60
a (38.7)
HIV positive/number tested* (%) 4/20 (20.0) 1/6 (16.7) 1/1(100) 9/11(81.8) 3/4 (75.0) 18/42 (42.9)
Urban Kenya
Number patients (N) 18,315 5,314 2,744 11,185 775 38,333
Number of blood cultures, n (% patients) 1,024(5.6) 452 (8.5) 193(7.0) 447(4.0) 22(2.8) 2,138(5.6)
Positive blood cultures, n (% cultures) 69(6.7) 76 (16.8) 33(17.1) 51(11.4) 1(4.5) 230 (10.8)
NTS recovered, n (% positive cultures) 5(7.2) 1(1.3) 0 (0) 1(2.0) 0(0.0) 7 (3.0)
b
aOne patient, an HIV-positive individual, had a recurrence of NTS bacteremia infection after one month in the rural site.
b0 of 1 (0%) adult with NTS was HIV-positive in Kibera.
doi:10.1371/journal.pone.0031237.t001
Table 2. NTS and S. Typhi cases by age category, rural and
urban Kenya, 2006–2009.
Age category Rural Kenya Urban Kenya
,5 Years NTS Cases 28 NTS Cases 5
Typhi Cases 1 Typhi Cases 35
NTS: Typhi ratio 28.0 NTS: Typhi ratio 0.14
.5 Years NTS Cases 32 NTS Cases 2
Typhi Cases 12 Typhi Cases 100
NTS: Typhi ratio 2.67 NTS: Typhi ratio 0.02
doi:10.1371/journal.pone.0031237.t002
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Blood (7–10 ml for adults and 1–3 ml for children) was
inoculated into commercially-produced broth bottles (BACTEC
Plus
TM/F Aerobic Plus
TM and Peds Plus
TM/F culture vials,
Becton Dickinson, Belgium) and incubated in an automated
BACTEC 9050 at 35uC for 1–5 days. Bottles with growth as
indicated by an audible alarm were removed, Gram-stained and
sub-cultured on standard media for bacteria identification using
routine microbiologic techniques [20]. Standard methods were
used to process stool specimens and identify pathogens [19].
Salmonella were identified by typical colony morphology and
confirmed by biochemical typing and serotyping [20]. Antimicro-
bial susceptibility patterns were determined using standard Kirby-
Bauer disc diffusion techniques [20].
S. Typhimurium isolates selected at random were lysed, digested
with Xbal and Blnl restriction enzymes and DNA fragments
separated by Pulse Field Gel Electrophoresis (PFGE) according to
the PulseNet protocol [21]. The gels were stained with ethidium
bromine, visualized and images were captured using gel
documentation system and analyzed using BioNumerics software
(Applied Maths, Inc, Austin, TX).
Data analysis
Differences in proportions were assessed by chi-square tests and
means by t-tests (Epi-Info
TM,version 3.4.3). Crude rates were
calculated as the number of cases of NTS bacteremia per 100,000
person-years of observation (pyo). Each participating individual
contributed person-time according to their dates of residence
within the surveillance area from October 1, 2006–September 30,
2009 in Asembo and March 1, 2007–February 28, 2009 in Kibera.
Two adjustments were applied to crude rates. First, a multiplier
was included for the percentage of persons visiting the referral
clinics that met criteria for blood culture and did not have a
culture done. The reasons for not getting cultured included the
clinician not recognizing that the patient met the case definition,
patient refusal, febrile patients presenting after two febrile persons
had already been sampled that day, or an in-patient having
already received intravenous antibiotics. The percentage of eligible
patients who did not receive a blood culture was calculated
separately for five age categories and for each indication for blood
culturing. A second adjustment was made based on the percentage
of persons identified with each of the indications for blood culture
at the household visit who visited clinics other than Lwak or
Tabitha for that illness. We assumed that those who visited
another clinic for the same syndrome had a comparable severity
and spectrum of etiologies to those that visited Lwak or Tabitha.
95% confidence intervals were calculated for crude rates using
Fisher’s method (PEPI, version 4.06) and for adjusted rates using
the delta method [22].
To estimate NTS bacteremia incidence in HIV-infected persons
$18 years old in the rural site, we adjusted persons with unknown
HIV status by applying the same proportion of HIV-positivity
among patients with NTS bacteremia for whom HIV status was
known. Population prevalence of HIV by age group was obtained
from the home-based HIV testing initiative in the surveillance
population in 2008 in which all adults were offered HIV testing
(KEMRI/CDC unpublished data). Age-specific HIV prevalence
rates were applied to obtain the age-specific person-years
denominators. Similar adjustment factors were applied as
described above.
Ethical review
The protocol and written informed forms for surveillance and
home-based HIV testing were reviewed and approved by the
Ethical Review Board of KEMRI and the Institutional Review
Board of CDC. For children less than 15 years old, parents, next of
kin or guardians gave written informed consent to permit the
children’s participation in the study. Children aged 7–14 years also
were required to give their written assent for participation.
Results
Of 3,578 blood cultures done in the rural site, 155 (4.3%) had a
pathogen isolated, of which 60 (38.7%) were NTS, the most
Table 3. NTS stool and blood culture isolates, rural and urban Kenya, 2006–2009.
Category Rural Kenya Urban Kenya
(n=60) (n=7)
Serotype Number (%) Serotype Number (%)
Blood Isolates Typhimurium 53 (88.3%) Typhimurium 6 (85.7%)
Enteritidis 6 (10.0%) Enteritidis 1 (14.3%)
Heidelberg 1 (1.7%)
(n=33) (n=14)
Serotype Number (%) Serotype Number (%)
Stool Isolates Typhimurium 21 (63.6%) Enteritidis 4 (28.6%)
Enteritidis 3 (9.1%) Typhimurium 3 (21.4%)
Virchow 3 (9.1%) Virchow 1 (7.1%)
Heidelberg 2 (6.1%) Heidelberg 1 (7.1%)
Newport 2 (6.1%) Muenchen 1 (7.1%)
Aberdeen 1 (3.0%) Agona 1 (7.1%)
Chailey 1 (3.0%) Stanleville 1 (7.1%)
Haifa 1 (7.1%)
Bovismorbificans 1 (7.1%)
doi:10.1371/journal.pone.0031237.t003
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(36.2% of isolates, Table 1). Twenty-three (38%) of rural NTS
bacteremia patients were hospitalized. In the urban site, 2,138
blood cultures were done, with a pathogen isolated from 230
(10.8%), of which 7 (3.0%) were NTS; the most common bacteria
isolated in the urban site were Salmonella typhi and S. pneumoniae.
The median age of pediatric NTS patients in both sites was 2 years
old and for patients $5 years was 32 years old. The sex
distribution of NTS cases was comparable (rural–51% female;
urban–57% female). Among rural children ,5 years with positive
blood cultures, 28/43 (65%) had NTS compared with 5/69 (7%)
of urban children (Table 1, p,0.0001). In the rural area, NTS
accounted for a greater proportion of bacteremia among febrile
patients (72% of isolates) than among SARI patients (30% of
isolates, p,0.005) or inpatients (36%, p=0.008). In the urban
area, the NTS isolation rate did not vary by indication for blood
culture (SARI 2%, fever 5%, p=0.3). Diarrhea was reported in
34% of patients with NTS bacteremia.
The predominant serotype of Salmonella causing bacteremia
differed in rural and urban Kenya, with NTS more common in
the rural site and Salmonella Typhi more common in the urban site
(Table 2) [23].
There was a broader distribution of NTS serotypes in stool than
blood (Table 3). S. Typhimurium was the predominant NTS blood
culture isolate in both rural and urban Kenya accounting for 88%
and 86% respectively. S. Typhimurium represented a greater
percentage of stool isolates in the rural site (64%) than the urban
site (21%, Table 3). Overall, 80% of S. Typhimurium isolates from
blood were multi-drug resistant (MDR) in the rural site (Figure 1).
The percentage of MDR among NTS blood isolates in the rural
site did not change significantly during the course of the study –
2007, 11/13 (85%), 2008 9/10 (90%), 2009, 11/17 (65%). Of 14
S. Typhimurium blood isolates from the rural site that underwent
PFGE, the predominant restriction pattern was found in 8 (57%)
by Xba1 and 9 (64%) by Bln1 restriction enzymes, all of which
were MDR (Figure 2). Three of six urban S. Typhimurium isolates
were MDR, two of which had the same predominant PFGE
pattern (by both Xba1 and Bln1) as the rural isolates.
There was no clear seasonal pattern to NTS bacteremia in
either site. In the rural site, a concomitant increase in the number
of NTS bacteremia cases and positive malaria cases was observed
in 2008–9 (Figure 3, Spearman’s correlation, p=0.018 for
children, p=0.16 adults, p=0.0001 overall). Positive malaria
blood smears were more common among NTS bacteremia
Figure 1. Antimicrobial resistance patterns among invasive S. Typhimurium (n=45) in rural western Kenya, 2006–2009. Chl is
chloramphenicol, sxt is trimethoprim-sulfamethoxazole, Tetr is tetracycline, Cip is ciprofloxacin, Nal is nalidixic acid, Amp is ampicillin, Sxz is
sulfisoxazole, Strep is streptomycin, Kan is kanamycin, Genta is gentamycin, Ctx is ceftriazone, Amc is amoxicillin-clavulinic acid, Multi Drug Resistance
(MDR) defined as resistance to chloramphenicol, trimethoprim-sulfamethoxazole and ampicillin.
doi:10.1371/journal.pone.0031237.g001
Figure 2. PFGE Gel patterns from XbaI restriction enzyme of Salmonella typhimurium isolates from blood and stool, western
Kenya, 2006–2009.
doi:10.1371/journal.pone.0031237.g002
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positive for pathogens other than NTS (10%), although not
statistically significant (p=0.14). The number of blood cultures
and isolation rate for bacteria other than NTS from blood culture
did not change substantively during the surveillance period,
suggesting the rising incidence of NTS bacteremia was not due to
Figure 3. Numbers of NTS bacteremia, smear-positive malaria cases and blood cultures done by quarter of the year, rural western
Kenya, 2006–2009. A. All persons (spearman rank correlation coefficient, 0.87, p=0.0003). B. Children ,5 years old (spearman rank correlation
coefficient, 0.66, p=0.018). C. Persons $5 years of age (spearman rank correlation coefficient, 0.43, p=0.18).
doi:10.1371/journal.pone.0031237.g003
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Nairobi.
In the rural site, 18 (43%) of 42 patients with NTS bacteremia
whose HIV status was known were HIV-positive (Table 1). The
HIV prevalence among NTS bacteremic patients .18 years was
80%, which was substantially higher than the adult HIV
prevalence in the community (17%, KEMRI/CDC unpublished
data). The one adult patient for whom HIV status was known in
the urban site was HIV-negative.
Overall crude and adjusted NTS incidence was higher in rural
Kenya (78 per 100,000 pyo and 580 per 100,000 pyo, respectively)
than in urban Kenya (13 per 100,000 pyo and 57 per 100,000 pyo,
respectively) (Table 4, p,0.0001 for urban: rural difference for
both crude and adjusted rates). In both sites, NTS incidence was
highest in children ,5 years. In the rural site, the crude rate
among HIV-infected persons .18 years was 334 per 100,000 pyo
(95% CI 274–394), with an adjusted rate of 1,555 per 100,000 pyo
(95% CI 956–2,155).
Among the 7 NTS-associated deaths (2 children and 5 older
persons), 1 occurred in the first 30 days after the date of the
positive blood culture, 3 died from 31–60 days, and 3 died from
61–90 days afterwards. The 30-day case-fatality ratio (CFR) was
0% for children and 3.1% for older persons; the 90-day CFR was
7.1% for children and 15.6% for older persons. Compared with
patients of the same age group who had a blood smear positive for
malaria, but were not bacteremic, the 90 day mortality among
NTS bacteremia cases in the rural Kenya site was 9 times higher
for patients ,5 years old and 68 times higher for patients $5 years
old (Table 5). In contrast, the 90 day mortality among patients
with NTS bacteremia was not significantly higher than that among
patients with bacteremia due to other bacteria. Verbal autopsies
on these 7 patients determined that 6 died of HIV/AIDS and 1
died of tuberculosis. No NTS-associated deaths occurred in the
urban site.
Discussion
NTS was the leading isolate from bloodstream infections in
rural Kenya, with incidence in the higher range of those found in
other rural African settings, where rates ranged from 88–330 cases
per 100,000 pyo [1,2,4,7,9,24–26]. In contrast to rural Kenya,
NTS bacteremia rates were much lower in the urban informal
settlement, where Salmonella Typhi predominated [23]. The most
likely explanation for the rural-urban disparity in NTS bacteremia
is that malaria is holo-endemic in the rural setting, while only
occurring sporadically through importation in high altitude
Nairobi (approximately 1,600 meters elevation). The association
between malaria and NTS bacteremia is well-described [25,27–
32]. NTS bacteremia is higher in those with current or recent
malaria and malarial anemia [2,9,26–30]. NTS rates were higher
Table 4. Crude and adjusted incidence rates of NTS bacteremia among rural and urban populations of Kenya, 2006–2009.
Age
In years Site
NTS
(n) Pyo*
Crude Rate per 100,000
Pyo
(95% CI)
Rate Extrapolation 1** per
100,000 Pyo
(95% CI)
Rate Extrapolation 2*** per
100,000 Pyo
(95% CI)
0–4 Rural 28 13,572 206 (138–298) 759 (542–916) 2085 (1181–2990)
Urban 5 9,595 52 (17–122) 208 (95–322) 260 (102–419)
5–9 Rural 6 11,312 53 (19–115) 150 (82–218) 389 (106–672)
Urban 1 8,049 12 (0.12–92) 25 (5–44) 37 (1–73)
10–17 Rural 1 16,756 6.0 (0.18–33) 18 (0–43) 24 (0–62)
Urban 0 8,017 0 (0–46) 0 (NA) 0 (NA)
18–49 Rural 19 25,015 76 (46–119) 155 (106–206) 367 (186–550)
Urban 1 26,752 3.7 (0.15–27) 7.5 (0–18) 11.2 (0–31)
.50 Rural 6 10362 58 (21–126) 145 (86–204) 232 (112–351)
Urban 0 2,120 0 (0–174) 0 (NA) 0 (NA)
Overall Rural 60 77,017 78 (59–100) 230 (142–317) 580 (229–934)
Urban 7 54,535 13 (5–26) 44 (0–89) 57 (0–122)
*Pyo=person-years of observation.
**Extrapolated for patients meeting indication for blood culture who were not cultured in the clinic.
***Extrapolated for patients meeting indication for blood culture who were not cultured in the clinic and those with same illness syndromes at the home visit who
sought care at area clinics besides Lwak and Tabitha clinics.
doi:10.1371/journal.pone.0031237.t004
Table 5. 90-day mortality among NTS bacteremia and malaria blood smear positive patients, rural
1 Kenya, 2006–2009.
Age
NTS cases 90 day
mortality rate (per
1,000 pyo)
2
B/S Positive malaria
cases 90 day mortality
rate (per 1,000 pyo)
Risk Ratio for 90 day
mortality NTS: Malaria
(95% CI)
Non-NTS bacteremia 90
day mortality rate (per
1,000 pyo)
Risk Ratio for 90 day mortality
NTS: Other pathogen (95% CI)
,5 Years 298 33 9.0 (2.4–37) 288 1.0 (0.14–7.9)
.5 Years 683 10 67 (26–172) 491 1.39 (0.49–4.0)
1There were no NTS related deaths reported in the urban area during the study period.
290-day mortality rate calculated as deaths in the 90 days after positive blood culture or malaria blood smear, annualized to 1,000 person-years of observation.
doi:10.1371/journal.pone.0031237.t005
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with a decreasing trend in malaria prevalence over several years in
Gambia, Tanzania and coastal Kenya [25,31,32]. The association
between NTS bacteremia and malaria is likely multi-factorial, and
may include hemolysis leading to dysfunctional macrophage
phagocytosis and release of free iron promoting bacterial growth
[2,25,27]. The risk of NTS bacteremia might be particularly high
with malarial anemia, which is very common among children in
western Kenya [2,28]. The increasing rate of NTS bacteremia
from 2008 onwards in western Kenya likely resulted, in part, from
an increasing malaria prevalence in the area [33].
Besides malaria, there are several other reasons for the rural/
urban difference in invasive Salmonella epidemiology. A possible
reason for high rates of typhoid in the urban site could be related
to the crowded living conditions and poor water and sanitation,
conditions more similar to Asian mega-cities where typhoid
predominates [23,34]. The lower rates of NTS bacteremia in
the urban site might also be related to the observation that those
who are terminally ill tend to leave Nairobi to go back ‘‘up-
country’’ to their ancestral homes where they would prefer to die.
As NTS bacteremia occurs more frequently in end-stage AIDS,
this migratory phenomenon would tend to decrease NTS
bacteremia in the city and increase it in rural areas. Another
possible explanation for the low urban NTS rates is that people
living in cities have less exposure to risk factors for NTS. There is
some evidence from developed countries that exposure to domestic
animals, particularly chickens which are common in rural Kenya,
might be a risk for NTS disease [6,8,27].
The high burden of NTS in adults in the rural site is also
influenced by the high prevalence of HIV, as has been shown in
other African settings [13,27,35–40]. The adjusted rate of NTS
among HIV-infected adults we found of 1,555 per 100,000 pyo
was slightly lower than that in Malawi (8,000 per 100,000),
Uganda (1,900 per 100,000) and elsewhere in Kenya (1,600–7,500
per 100,000) [36,38–40]. This lower rate in Kenya might be due
to the institution of the home-based HIV counseling and testing
program in 2008 that identified many HIV-infected persons in
early stages of infection (median CD4 400 cells/mm
3), when they
would be less susceptible to NTS bacteremia, as well as leading to
the initiation of cotrimoxazole prophylaxis among many HIV-
infected persons, which has been shown to prevent NTS
bacteremia [41]. Almost all deaths following NTS bacteremia in
our study were HIV-related, according to verbal autopsy. This
suggests that while NTS bacteremia might not be the proximate
cause of death, it can serve as an indicator of end-stage AIDS and
of imminent death from other HIV-related causes. Immune
reconstitution with anti-retrovirals and/or cotrimoxazole prophy-
laxis can reduce the risk of NTS bacteremia [36,38,41]. Third,
because we not only cultured febrile patients, but also those with
severe acute respiratory illness, we might have identified more
NTS bacteremia. NTS bacteremia commonly presents with
respiratory symptoms in children, although its role in causing
pneumonia based on lung aspiration studies is doubtful [2,42].
Alternatively, patients with severe respiratory illness due to
another cause can be simultaneously bacteremic with NTS,
particularly among HIV-infected persons [2,11,13,35].
We found a lower mortality from episodes of NTS bacteremia
than other studies. Because free, high-quality care was offered to
surveillance participants, ill persons likely came to the clinic at
earlier stages of illness, so that milder cases of NTS bacteremia
might have been captured, as suggested by the observation that
62% of NTS bacteremia patients in the rural site were treated as
outpatients. Most studies have been done among hospitalized
patients, where case-fatality rates for NTS bacteremia were much
higher than we found, ranging from 4–27% for children and from
22–47% for adults [27].
S. Typhimurium was the dominant serotype causing blood-
stream infections in both urban and rural sites, in contrast to a
much broader serotype distribution among contemporaneous
NTS stool isolates [2,3,6,8]. Rises in multi-drug resistant S.
Typhimurium have been temporally related to increased numbers
of NTS bacteremia cases in Malawi from 2001–2004 [13].
Genomic sequencing of these invasive multi-drug resistant S.
Typhimurium isolates from Malawi, and of contemporaneous
isolates from coastal and urban Kenya, revealed a similar clone,
ST313 [14]. It was postulated that genomic degradation in this
NTS clone created characteristics more similar to Salmonella Typhi,
changes that led to greater invasive potential [14]. Without genetic
sequencing, we lack conclusive evidence that the predominant
multi-drug resistant strain in our sites were the ST313 clone,
although the predominant PFGE pattern had an antimicrobial
resistance profile similar to previously identified ST313 isolates
from Kenya [14].
Our study had several limitations. First, in making adjustments
of bacteremia rates, we made certain assumptions – NTS isolation
rates would be the same among those meeting indications for
blood culture who did not get cultured and that those patients
under surveillance who attended another clinic for their illness
would also have similar isolation rates to those who went to Lwak
and Tabitha. Both assumptions might be subject to biases.
Nonetheless, the crude rates are clearly an underestimate of the
true rate in the community, due to limited health-care utilization
and insensitivity of blood cultures, and the adjustments provide
reasonable upward adjustments, although should be considered
the maximal rate. Second, only 60% of patients with NTS
bacteremia had a confirmed HIV status and we assumed that
those not tested had the same proportion HIV-positive as those
tested. This assumption also might have been subject to differential
bias. Third, NTS is a more robust and antibiotic resistant than the
more fastidious Gram-positive bacteria, particularly Streptococcus
pneumoniae, and therefore we can only claim that NTS was the most
common isolate from blood culture in the rural site, rather than
the most common cause of bacteremia.
Regardless of these limitations, NTS bacteremia clearly
continues to cause a substantial burden of morbidity among
children and HIV-infected adults in rural Kenya, warranting
further investigation to define amenable risk factors, best treatment
guidelines and new interventions, such as NTS vaccines currently
under development [43].
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